- Home
- OPFI vs DRTS Comparison
OPFI vs DRTS Comparison
Compare OPFI & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- DRTS
- Stock Information
- Founded
- OPFI 2009
- DRTS 2015
- Country
- OPFI United States
- DRTS Israel
- Employees
- OPFI N/A
- DRTS N/A
- Industry
- OPFI Finance: Consumer Services
- DRTS Medical/Dental Instruments
- Sector
- OPFI Finance
- DRTS Health Care
- Exchange
- OPFI Nasdaq
- DRTS Nasdaq
- Market Cap
- OPFI 290.9M
- DRTS 259.4M
- IPO Year
- OPFI N/A
- DRTS N/A
- Fundamental
- Price
- OPFI $10.52
- DRTS $2.71
- Analyst Decision
- OPFI Buy
- DRTS Strong Buy
- Analyst Count
- OPFI 2
- DRTS 2
- Target Price
- OPFI $7.50
- DRTS $8.00
- AVG Volume (30 Days)
- OPFI 2.6M
- DRTS 103.2K
- Earning Date
- OPFI 03-05-2025
- DRTS 03-06-2025
- Dividend Yield
- OPFI 1.09%
- DRTS N/A
- EPS Growth
- OPFI 775.86
- DRTS N/A
- EPS
- OPFI 0.38
- DRTS N/A
- Revenue
- OPFI $260,661,000.00
- DRTS N/A
- Revenue This Year
- OPFI N/A
- DRTS N/A
- Revenue Next Year
- OPFI $6.51
- DRTS N/A
- P/E Ratio
- OPFI $28.93
- DRTS N/A
- Revenue Growth
- OPFI 23.85
- DRTS N/A
- 52 Week Low
- OPFI $2.35
- DRTS $1.75
- 52 Week High
- OPFI $17.73
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- OPFI 37.15
- DRTS 30.79
- Support Level
- OPFI $10.09
- DRTS $2.65
- Resistance Level
- OPFI $12.05
- DRTS $3.19
- Average True Range (ATR)
- OPFI 1.29
- DRTS 0.16
- MACD
- OPFI -0.67
- DRTS -0.07
- Stochastic Oscillator
- OPFI 5.65
- DRTS 7.43
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.